人类乳腺癌qBiomarker体细胞突变PCR芯片 breast Cancer qBiomarker Mutation PCR Array
人类乳腺癌qBiomarker体细胞突变PCR芯片 breast Cancer qBiomarker Mutation PCR Array
人类乳腺癌qBiomarker体细胞突变PCR芯片 breast Cancer qBiomarker Mutation PCR Array
运费 ￥0.00
“英拜为您实验加速” 技术服务网址：http://www.yingbio.com/ 服务热线：400-696-6643、 18019265738 邮箱：daihp@yingbio.com 、 huizhang1228@foxmail.com Breast Cancer qBiomarker Mutation PCR Array 人类乳腺癌qBiomarker体细胞突变PCR芯片
人类乳腺癌qBiomarker体细胞突变PCR芯片是一个翻译研究工具,用于快速,准确,全面剖析人类乳腺癌前体细胞突变的基因: AKT1, APC, BRAF, CDH1, CTNNB1, HRAS, KRAS, NRAS, PIK3CA, and TP53.这些突变保证广泛的研究,以提高致癌作用的理解和鉴定潜在的药物靶点。已有许多研究通过单个和多个体细胞突变状态信息鉴定关键信号转导中断。例如,EGFR和KRAS基因的突变状态可以预测某些药物针对这些分子的生理反应。人类乳腺癌qBiomarker体细胞突变PCR芯片以其全面的内容覆盖范围，用于研究乳腺癌的环境突变且有潜力用于发现靶向药物的生物标记和验证这些癌症和其他这些突变已确定的癌症。这个芯片包含84个DNA突变序列用于检测在人类乳腺癌中最频繁的、功能验证的、有生物学重要意义的突变。这些突变的选择根据全面的体细胞突变数据库和同行评审的科学文献，代表最频繁重复编译的体细胞突变汇编自超过6000个乳腺癌样本。简单的产品模式和操作程序让任何一个具备实时定量PCR仪的实验室都可进行常规的体细胞突变分析。 AKT1: 1 Assay The mutation assay detects the best known AKT1 mutation, c.49G>A, p.E17K. This is a PH domain mutation that results in constitutive targeting of AKT1 to plasma membrane. APC: 1 Assay The most commonly detected APC inactivation mutations are mainly composed of truncation mutations (due to nonsense mutations and frameshift mutations) and point mutations between codons 1250 and 1578. BRAF: 2 Assays There are two major classes of BRAF mutations. One class leads to increased BRAF kinase activity, such as the p. V600E mutation. The other class leads to impaired kinase activity, such as the p.G469A mutation. CDH1: 3 Assays The top CDH1 mutations either are missense mutations or frameshift mutations that lead to C-terminal truncation and secreted E-cadherin fragments. CTNNB1: 1 Assay The most frequently detected CTNNB1/beta-catenin mutations result in abnormal signaling in the WNT signaling pathway. The mutated codons are mainly several serine/threonine residues targeted for phosphorylation by GSK-3beta. HRAS: 1 Assay The most important HRAS mutations identified in cancers occur at codons 12 KRAS: 5 Assays The mutation assays include the most frequently occurring mutations in KRAS codons 12, 13, and 61. Mutations at these positions result in reduced intrinsic GTPase activity and/or cause KRAS to become unresponsive to RasGAP. NRAS: 1 Assay The most important NRAS mutation in breast cancer occurs at codon 61. PIK3CA: 13 Assays The most frequently occurring PIK3CA mutations mainly belong to two classes: gain-of-function kinase domain activating mutations and helical domain mutations that mimic activation by growth factors. TP53: 56 Assays The most frequently detected somatic mutations in TP53 are largely composed of DNA-binding domain mutations which disrupt either DNA binding or protein structure Overview of the qBiomarker Somatic Mutation PCR Array / Assay Protocol
Overview of the qBiomarker Somatic Mutation PCR Array / Assay Protocol. Principle of Mutant Discrimination with ARMS®  |
- 姓名
- 电话号码
- 电子邮箱
- 公司名称
- 地址
- 留言*
